Table 1.
Demographic and clinical data of children with Guillain–Barré syndrome.
| Parameter | n = 62 cases (%) |
|---|---|
| Age (years): range | 1.5–16 |
| Mean ± standard deviation | 8.0 ± 4.7 years |
| Gender (male: female) | 26:36 (42/58) |
| Season | |
| Summer | 36 (58) |
| Fall | 6 (10) |
| Winter | 10 (16) |
| Spring | 10 (16) |
| Antecedent infection | |
| Upper respiratory infection | 42 (67.7) |
| Gastrointestinal infection | 16 (25.8) |
| Viral infection | 4 (6.5) |
| Diagnosis | |
| AIDP | 40 (64.5) |
| AMAN | 8 (13) |
| AMSAN | 6 (9.5) |
| MFS | 4 (6.5) |
| Undefined diagnosis | 4 (6.5) |
| Clinical manifestation | |
| Autonomic manifestation | 11 (17.7) |
| Cranial nerve affection | 15 (24.2) |
| Facial palsy | 17 (27.4) |
| Bulbar palsy | 14 (22.5) |
| Neck muscle affection | 24 (38.7) |
| Treatment | |
| IVIG | 30 (48.4) |
| Plasmapheresis | 32 (51.6) |
| Required mechanical ventilation | |
| Yes | 24 (38.7) |
| No | 38 (61.3) |
| Prognosis | |
| Complete recovery | 26 (42) |
| Residual deficit | 24 (38.7) |
| Death | 12 (19.3) |
AIDP, acute inflammatory demyelinating polyneuropathy; AMAN, acute motor axonal neuropathy;
AMSAN, acute motor sensory axonal neuropathy; IVIG, intravenous immunoglobulin; MFS, Miller Fisher syndrome.